Results
1 -
10 of
115R. Bednár, L. Cvak, J. Cejka, B. KratochvÃl, I. CÃsarová and A. Jegorov.
Cabergoline, form VII, Acta Cryst. (2004). E60, o1167-o1169Â Â Â Â Liu Haichao, Jia Yanxing.
Ergot alkaloids: synthetic approaches to lysergic acid and clavine alkaloids, Nat. Prod. Rep., 2017 Management of medically refractory prolactinoma, Journal of Neuro-Oncology Cabergoline modulation of ??-subunits and FSH secretion in a gonadotroph adenoma, Journal of Endocrinological Investigation Secondary resistance to cabergoline therapy in a macroprolactinoma: a case report and literature review, Pituitary Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion, Pituitary Cabergoline, prolactin and melatonin release at night in healthy men, Journal of Endocrinological Investigation The selective agonist of dopamine D2 receptors cabergoline decreases alcohol consumption and increases the level of DRD2 mRNA in the brain of rats with chronic alcohol intoxication, Neurochemical Journal